About

About

Learn more about our mission and team.

Mission

Our mission is to transform the standard of care for hypertrophic cardiomyopathy and related conditions.

Our Science

About Us

Braveheart’s team represents an accomplished, mission-driven group of people committed to advancing care for patients.

Leadership

Travis Murdoch, M.D.
Chief Executive Officer and Board Director
Read More
Michele Anderson
Chief Development Officer
Read More
Tyler Chavez, Ph.D.
Chief Business Officer
Read More
Emil deGoma, M.D.
Chief Medical Officer
Read More
Marc Evanchik, M.S.
Chief Scientific Officer
Read More
Paul Rickey
Chief Financial Officer
Read More
Carlos L. del Rio, Ph.D.
Senior Vice President, Cardiovascular Research & Translational Science
Read More
Brittany de Temple
Senior Vice President, Development Operations
Read More

Team

Andrew Alwood
Lee Bockus, M.D., Ph.D.
Jennifer Brooks
Sara Butler
Jill DeLotell
Natalie Dement, J.D.
Joanne Dill
Emy DiNatale
Amy Feng, Ph.D.
Matt Kelly
Eddie Kim
Garland Lee, Pharm.D.
Caspar Lin
Peishan Liu-Snyder, M.D., Ph.D.
Craig Luis, Pharm.D.
Joanne McCaigue
Debbie Morales
Ali Moulton
Kelly Mumma
Steph Palencia
Niki Patel, Pharm.D.
Chris Peters
Tasfia Rafiuddin, Pharm.D.
Jordin Rice
Peter Riebling
Sheerin K. Shahidi-Latham, Ph.D.
Jessica Tolomeo
Arian Zari
Tim Zhou

Board of Directors

Chris Viehbacher
Chair of the Board
Jasper Bos, Ph.D.
Board Director
Erez Chimovits, M.B.A., M.Sc.
Board Director
Jason Coloma, Ph.D., M.B.A.
Board Director
Tim Lohoff, Ph.D.
Board Director
David Lubner
Board Director
David Malek, M.B.A.
Board Director
Vineeta Agarwala, M.D., Ph.D.
Board Observer
Evan Caplan, M.D., M.B.A.
Board Observer
Neel Varshney, M.D.
Board Observer

Investors

Interested in joining our team?

Learn more about our openings.

Learn More